Cervical Cancer in Ethiopia: The Effect of Adherence to Radiotherapy on Survival

被引:25
|
作者
Moelle, Ulrike [1 ]
Mathewos, Assefa [2 ]
Aynalem, Abreha [2 ]
Wondemagegnehu, Tigeneh [2 ]
Yonas, Bekuretsion [2 ]
Begoihn, Matthias [1 ]
Addissie, Adamu [2 ]
Unverzagt, Susanne [1 ]
Jemal, Ahmedin [3 ]
Thomssen, Christoph [1 ]
Vordermark, Dirk [1 ]
Kantelhardt, Eva J. [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Halle, Saale, Germany
[2] Addis Ababa Univ, Addis Ababa, Ethiopia
[3] Amer Canc Soc, Atlanta, GA 30329 USA
来源
ONCOLOGIST | 2018年 / 23卷 / 09期
关键词
Cervical cancer; Radiotherapy; Sub-Saharan Africa; Survival; Adherence; SQUAMOUS-CELL CARCINOMA; DOSE-RATE BRACHYTHERAPY; RADIATION-THERAPY; UTERINE CERVIX; WORLDWIDE BURDEN; EXTERNAL-BEAM; AFRICA; IRRADIATION; GUIDELINES; EXPERIENCE;
D O I
10.1634/theoncologist.2017-0271
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Discontinuation of radiotherapy (RT) for cervical cancer (CC) in sub-Saharan Africa is common because of patient-and health service-related reasons. This analysis describes toxicities and the effect of adherence on survival. Materials and Methods. A total of 788 patients with CC (2008-2012) who received RT at Addis Ababa University Hospital were included. External beam RT without brachytherapy was performed according to local guidelines. We previously described survival and prognostic factors. Now we analyzed adherence and survival according to total doses received. Adjustment via multivariate cox regression analysis was done. Results. One-year overall survival (OS) after radical RT (n=180) for International Federation of Gynecology and Obstetrics (FIGO) stages IIA-IIIA was 89% for discontinuation (< 72 Gy) and 96% for adherence (>= 72 Gy; hazard ra tio [HR], 1.3; 95% confidence interval [CI], 0.5-3.3). One-year OS after nonradical RT (n=389) for FIGO stages IIIB-IVA was 71% for discontinuation (< 40 Gy) and 87% for adherence (44-50 Gy; HR, 3.1; 95% CI, 1.4-6.9). One-year OS for FIGO stages IIIB-IVB (n=219) after one compared with two or more palliative single fractions of 10 Gy were 14% and 73% respectively (HR, 7.3; 95% CI, 3.3-16). Reasons for discontinuation were toxicities, economic background, and RT machine breakdown. Grade 1-2 late toxicities were common (e.g., 30% proctitis, 22% incontinence). Grade 3 early and late toxicities were seen in 5% and 10% respectively; no grade 4 toxicities occurred. Conclusion. Patients who adhered to guideline-conforming RT had optimum survival. Better supportive care, brachytherapy to reduce toxicities, socioeconomic support, and additional radiation capacities could contribute to better adherence and survival.
引用
收藏
页码:1024 / 1032
页数:9
相关论文
共 50 条
  • [41] Targeting autophagy promotes the antitumor effect of radiotherapy on cervical cancer cells
    Meng, Fanjie
    Yan, Ying
    Zhou, Li
    Zhao, Song
    Sun, Lingyan
    Yu, Huiying
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [42] Adherence to Treatment and Follow-Up of Precancerous Cervical Lesions in Ethiopia
    Stroetmann, Clara Yolanda
    Gizaw, Muluken
    Alemayehu, Rahel
    Wondimagegnehu, Abigiya
    Rabe, Friedemann
    Santos, Pablo
    Mchome, Bariki
    Mmbaga, Blandina Theophil
    Addissie, Adamu
    Kantelhardt, Eva Johanna
    ONCOLOGIST, 2024, : e655 - e664
  • [43] Impact of adherence to sedlis criteria for postoperative adjuvant radiotherapy in lymph node-negative cervical cancer
    Kim, T. H.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 353 - 353
  • [44] The effect of marriage on stage at diagnosis and survival in women with cervical cancer
    El Ibrahimi, Sanae
    Pinheiro, Paulo S.
    PSYCHO-ONCOLOGY, 2017, 26 (05) : 704 - 710
  • [45] Cancer risk following radiotherapy of cervical cancer
    Boice, J.D. Jr.
    Day, N.E.
    1600, Publ by Martinus Nijhoff Publ, Dordrecht, Neth
  • [46] Stage IA-IIA cervical cancer: Disparities in adherence to treatment guidelines and survival in California
    Pfaendler, K. S.
    Chang, J.
    Ziogas, A.
    Bristow, R. E.
    Penner, K. R.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 10 - 11
  • [47] GUIDLINE ADHERENCE AND SURVIVAL IN LOCALLY ADVANCED CERVICAL CANCER IN THE NETHERLANDS BETWEEN 2009-2016
    Wenzel, H.
    Bekkers, R.
    Lemmens, V.
    Nijman, H.
    van der Aa, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A79 - A81
  • [48] Radiotherapy and survival in breast cancer
    Buchholz, Thomas A.
    LANCET, 2011, 378 (9804): : 1680 - 1682
  • [49] Technological advances in radiotherapy for cervical cancer
    Walsh, Lorraine
    Morgia, Marita
    Fyles, Anthony
    Milosevic, Michael
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) : 512 - 518
  • [50] Definitive radiotherapy for cervical esophageal cancer
    Cao, Caineng
    Luo, Jingwei
    Gao, Li
    Xu, Guozhen
    Yi, Junlin
    Huang, Xiaodong
    Wang, Kai
    Zhang, Shiping
    Qu, Yuan
    Li, Suyan
    Xiao, Jianping
    Zhang, Zhong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (02): : 151 - 155